Mindi Lee Morrow, LPN | |
180 Marshall St, Cameron, WV 26033-9781 | |
(304) 238-3929 | |
Not Available |
Full Name | Mindi Lee Morrow |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 180 Marshall St, Cameron, West Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710696083 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | 22916 (West Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mindi Lee Morrow, LPN 100 Teletech Dr, Moundsville, WV 26041-2790 Ph: (304) 843-3379 | Mindi Lee Morrow, LPN 180 Marshall St, Cameron, WV 26033-9781 Ph: (304) 238-3929 |
News Archive
Sequenom, Inc., a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced the publication of a clinical validation study on the MaterniT GENOME laboratory-developed test in the American Journal of Obstetrics and Gynecology.
A Paravalvular regurgitation, or leakage, commonly affects valvular prostheses, particularly artificial valves placed percutaneously according to data presented at the 2013 Transcatheter Cardiovascular Therapeutics (TCT) conference.
St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of its Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).
Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced today that the European Medicines Agency has granted Advanced Therapy Medicinal Product classification for its novel stem cell drug 'Stempeucel' which will be used for the treatment of Thromboangiitis Obliterans (TAO).
› Verified 9 days ago